As of Nov 22
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +15.30% increase from the last price of 26.02.
The current consensus among 5 polled investment analysts is to Hold stock in NxStage Medical Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.